| Literature DB >> 36154957 |
Justine S Gortney1, Joseph P Fava2, Andrew D Berti3, Brittany Stewart4.
Abstract
INTRODUCTION: Objective structured clinical examinations (OSCEs,) provided in-person or virtually, assess student pharmacist readiness for advanced pharmacy practice experiences (APPEs). During the COVID-19 pandemic in 2020, it was necessary for many educators to design and implement virtual OSCEs (vOSCEs). Impact on student performance utilizing in-person vs. vOSCE has not been well evaluated. The objective of this study was to determine if a difference existed in student performance when comparing in-person vs. vOSCE in a third year (P3) pharmacy pre-APPE capstone course.Entities:
Keywords: Assessment; Objective structured clinical examinations; Standardized patients; Virtual learning
Mesh:
Year: 2022 PMID: 36154957 PMCID: PMC9352434 DOI: 10.1016/j.cptl.2022.07.026
Source DB: PubMed Journal: Curr Pharm Teach Learn ISSN: 1877-1297
Description of objective structured clinical examination stations.
| OSCE station | Description of activity | Rubric / question allotment |
|---|---|---|
| #1 Medication History | Accurately collect a medication history from a standardized patient and utilize appropriate patient interviewing and communication skills | Communication elements (45%) Technical elements (45%) Global assessment (10%) |
| #2 OTC Counseling | Apply the SCHOLAR-MAC method to collect information, assess the SP's self-care related issue, and provide an appropriate recommendation for self-care treatment or referral | SCHOLAR-MAC interview (45%) Patient impression, OTC selection and counseling (45%) Global assessment (10%) |
| #3 Renal Dosing in Hospitalized Patient | Evaluate a written patient case to determine factors and medications that contribute to AKI, calculate serum creatinine clearance, and perform appropriate renal dose adjustments to develop a care plan | Calculation of creatinine clearance (26%) Identification of patient contributors to AKI (16%) Review of all medications to determine status of discontinue, modify, or continue (32%) Description of dosing modifications (10%) Monitoring (16%) |
| #4 Prescription Verification | Evaluate new and refill prescription orders based on patient-specific data provided. Three prescriptions with matching prescription history provided. | Decision to accept or reject prescription as written and entered into pharmacy system (50%) Description of decision making process (50%) |
| #5 DRP identification and Solution | Identify potential DRPs based on the medication history elicited from the SP in station #1 and provide solution(s) for the identified problems. | Review of all medications to assign a potential DRP status (50%) Describe three most important DRPs and solution (50%) |
| #6 Vaccine Needs Assessment | Evaluate a written patient case to perform a vaccine needs assessment and provide appropriate recommendations. | Develop a vaccination plan for the next 12 months (63%) Develop a vaccination plan for specified future date (i.e. 30 years in future) (37%) |
AKI = acute kidney injury; DRP = drug related problem; OSCE = objective structured clinical examination; OTC = over-the-counter; SP = standardized patient.
Elements included introduction, relationship building, acknowledging and responding to emotions, rapport, question style, verbal/non-verbal expression, health literacy, confidence, professionalism and organization.
Elements included specific questions surrounding all medication-related products, allergies, how/why the patient is using the medication, problem inquiry, procurement and storage of medications, potential substances of abuse, and vaccination status.
Global assessment question was “I would seek help/advice from this pharmacist in the future.”
Stations #5 and #6 were introduced in 2021 and were not assessed in the 2019 in-person OSCE.
Student scores for OSCE and vOSCE assessments.
| Station | 2019 formative OSCE | 2019 summative OSCE | 2021 formative vOSCE | 2021 summative vOSCE | |
|---|---|---|---|---|---|
| Median (Interquartile Range) | |||||
| #1 Medication History (100) | 88.2 (81.5–94.6) | 98.1 (95.2–100) | 96.9 (91.9–99.0) | 96.0 (93.0–98.5) | .002 |
| #2 OTC Counseling (100) | 71.4 (61.9–78.6) | 84.5 (76.5–90.0) | 75.5 (64.6–79.9) | 85.0 (78.5–90.5) | .30 |
| #3 Renal Dosing in Hospitalized Patient (19) | 15.0 (13.7–16.3) | 18.0 (17.1–19.0) | 15.0 (14.1–16.0) | 18.8 (17.5–19.0) | .23 |
| #4 Prescription Verification (6) | 5.0 (4.0–5.5) | 5.7 (5.2–6.0) | 5.5 (5.5–5.5) b | 5.7 | .12 |
| #5 DRP Identification and Solution (12) | Not offered in 2019 | Not offered in 2019 | 9.5 (8.0–10.5) | 11.5 (11.0–12.0) | Not applicable |
| #6 Vaccine Needs Assessment (24) | Not offered in 2019 | Not offered in 2019 | 18.0 (18.0–21.0) | 21.0 (21.0–24.0) | Not applicable |
DRP = drug related problem; OSCE = objective structured clinical examination; OTC = over-the-counter; v = video.
P < .001 using Wilcoxon Signed-Rank test within same OSCE type/year.
Ninety-five examinees' data included in analysis; one excluded due to absence of student on test day resulting in make-up exam.
Nintey-one examinees data included; two excluded due to computer difficulties resulting in paper exam.
Students offered remediation by station.
| Station Type | Students requiring remediation in 2019 OSCE ( | Students requiring remediation in 2021 vOSCE (n = 96), n (%) |
|---|---|---|
| #1 Medication History | 0 (0) | 1 (1) |
| #2 OTC Counseling | 3 (3.1) | 6 (6.3) |
| #3 Renal Dosing in Hospitalized Patient | 7 (7.2) | 4 (4.2) |
| #4 Community Medication Order | 0 (0) | 2 (2.1) |
| #5 DRP Identification and Solution | Not applicable | 0 (0) |
| #6 Vaccine Needs Assessment | Not applicable | 7 (7.3) |
DRP = drug related problem; OSCE = objective structured clinical examination; OTC = over-the-counter; v = video.